The role of the thiol group in protein modification with methylglyoxal

被引:27
作者
Acimovic, Jelena M. [1 ]
Stanimirovic, Bojana D. [1 ]
Mandic, Ljuba M. [1 ]
机构
[1] Univ Belgrade, Fac Chem, Dept Biochem, Belgrade 11158, Serbia
关键词
methylglyoxal; protein thiol group reaction; protein modification and cross-linking; AGEs; GLYCATION END-PRODUCTS; BOVINE SERUM-ALBUMIN; DIABETES-MELLITUS; MAILLARD REACTION; ANTIOXIDANT PROPERTIES; AMINO-ACIDS; COMPLICATIONS; OXIDATION; PLASMA; MICROANGIOPATHY;
D O I
10.2298/JSC0909867A
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Methylglyoxal is a highly reactive a-oxoaldehyde with elevated production in hyperglycemia. It reacts with nucleophilic Lys and Arg side-chains and N-terminal amino groups causing protein modification. In the present study, the importance of the reaction of the Cys thiol group with methylglyoxal in protein modification, the competitiveness of this reaction with those of amino and guanidine groups, the time course of these reactions and their role and contribution to protein cross-linking were investigated. Human and bovine serum albumins were used as model systems. It was found that despite the very low levels of thiol groups on the surface of the examined protein molecules (approx. 80 times lower than those of amino and guanidino groups), a very high percentage of it reacts (25-85%). The amount of reacted thiol groups and the rate of the reaction, the time for the reaction to reach equilibrium, the formation of a stable product and the contribution of thiol groups to protein cross-linking depend on the methylglyoxal concentration. The product formed in the reaction of thiol and an insufficient quantity of methylglyoxal (compared to the concentrations of the groups accessible for modification) participates to a significant extent (4%) to protein cross-linking. Metformin applied in equimolar concentration with methylglyoxal prevents its reaction with amino and guanidino groups but, however, not with thiol groups.
引用
收藏
页码:867 / 883
页数:17
相关论文
共 44 条
[1]   Glyoxal and methylglyoxal trigger distinct signals for map family kinases and caspase activation in human endothelial cells [J].
Akhand, AA ;
Hossain, K ;
Mitsui, H ;
Kato, M ;
Miyata, T ;
Inagi, R ;
Du, J ;
Takeda, K ;
Kawamoto, Y ;
Suzuki, H ;
Kurokawa, K ;
Nakashima, I .
FREE RADICAL BIOLOGY AND MEDICINE, 2001, 31 (01) :20-30
[2]   Chemical modification of muscle protein in diabetes [J].
Alt, N ;
Carson, JA ;
Alderson, NL ;
Wang, YP ;
Nagai, R ;
Henle, T ;
Thorpe, SR ;
Baynes, JW .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2004, 425 (02) :200-206
[3]   Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes [J].
Aso, Y ;
Inukai, T ;
Tayama, K ;
Takemura, Y .
ACTA DIABETOLOGICA, 2000, 37 (02) :87-92
[4]   Heterogeneity and oxidation status of commercial human albumin preparations in clinical use [J].
Bar-Or, D ;
Bar-Or, R ;
Rael, LT ;
Gardner, DK ;
Slone, DS ;
Craun, ML .
CRITICAL CARE MEDICINE, 2005, 33 (07) :1638-1641
[5]   Glycoxidation and lipoxidation in atherogenesis [J].
Baynes, JW ;
Thorpe, SR .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (12) :1708-1716
[6]   INCREASED COLLAGEN-LINKED PENTOSIDINE LEVELS AND ADVANCED GLYCOSYLATION END-PRODUCTS IN EARLY DIABETIC NEPHROPATHY [J].
BEISSWENGER, PJ ;
MOORE, LL ;
BRINCKJOHNSEN, T ;
CURPHEY, TJ .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (01) :212-217
[7]   Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus [J].
Berg, TJ ;
Bangstad, HJ ;
Torjesen, PA ;
Osterby, R ;
Bucala, R ;
Hanssen, KF .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (06) :661-665
[8]  
BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315
[9]   Ionization-reactivity relationships for cysteine thiols in polypeptides [J].
Bulaj, G ;
Kortemme, T ;
Goldenberg, DP .
BIOCHEMISTRY, 1998, 37 (25) :8965-8972
[10]   ALBUMIN STANDARDS AND MEASUREMENT OF SERUM ALBUMIN WITH BROMCRESOL GREEN [J].
DOUMAS, BT ;
WATSON, WA ;
BIGGS, HG .
CLINICA CHIMICA ACTA, 1971, 31 (01) :87-&